Pomegranate juice: A heart-healthy fruit juice

Nutrition Reviews

Volumn 67, Issue 1, 2009, Pages 49-56

  Basu, Arpita ^a   Penugonda, Kavitha ^a  

^a OKLAHOMA STATE UNIVERSITY   (United States)

Author keywords

Antioxidants; Atherosclerosis; Ellagic acid; Hypertension; Pomegranates

Indexed keywords

ANTHOCYANIN; DIPEPTIDYL CARBOXYPEPTIDASE; ELLAGIC ACID; ELLAGITANNIN; ENDOTHELIAL NITRIC OXIDE SYNTHASE; HIGH DENSITY LIPOPROTEIN; LOW DENSITY LIPOPROTEIN; POMEGRANATE EXTRACT; PUNICALAGIN; THROMBOSPONDIN; TRANSFORMING GROWTH FACTOR BETA1; UNCLASSIFIED DRUG; ANTIINFLAMMATORY AGENT; ANTIOXIDANT; FLAVONOID; PHENOL DERIVATIVE; POLYPHENOLS;

ANTIHYPERTENSIVE ACTIVITY; ANTIINFLAMMATORY ACTIVITY; ANTIOXIDANT ACTIVITY; ARTERIAL WALL THICKNESS; ATHEROSCLEROSIS; ATHEROSCLEROTIC PLAQUE; BIOAVAILABILITY; DIET SUPPLEMENTATION; DRUG SAFETY; DRUG TOLERANCE; GLUCOSE BLOOD LEVEL; HEART PROTECTION; HUMAN; HYPERTENSION; INFLAMMATION; LIPID BLOOD LEVEL; LIPID PEROXIDATION; NON INSULIN DEPENDENT DIABETES MELLITUS; NONHUMAN; OXIDATIVE STRESS; POMEGRANATE JUICE; REVIEW; SYSTOLIC BLOOD PRESSURE; ANIMAL; BEVERAGE; BLOOD; BLOOD PRESSURE; CARDIOVASCULAR DISEASE; CHEMISTRY; CLINICAL TRIAL; DIABETES MELLITUS; DRUG EFFECT; FRUIT; MOUSE; POMEGRANATE; RAT;

LYTHRACEAE; MURINAE; MUS;

ANIMALS; ANTI-INFLAMMATORY AGENTS; ANTIOXIDANTS; ATHEROSCLEROSIS; BEVERAGES; BIOLOGICAL AVAILABILITY; BLOOD PRESSURE; CARDIOVASCULAR DISEASES; CLINICAL TRIALS AS TOPIC; DIABETES MELLITUS; DIABETES MELLITUS, TYPE 2; FLAVONOIDS; FRUIT; HUMANS; HYPERTENSION; LIPID PEROXIDATION; MICE; OXIDATIVE STRESS; PEPTIDYL-DIPEPTIDASE A; PHENOLS; PUNICACEAE; RATS;

EID: 64049109979     PISSN: 00296643     EISSN: 17534887     Source Type: Journal    
DOI: 10.1111/j.1753-4887.2008.00133.x     Document Type: Review

References (84)

1. Kung HC, Hoyert DL, Xu J, Murphy SL. Deaths: final data for 2005. Natl Vital Stat Rep. 2008;56:1-120.
2. Burrows NR, Parekh S, Li Y, Geiss LS. Prevalence of selfreported cardiovascular disease among persons aged 35 years with diabetes - United States, 1997-2005. MMWR. 2007;56:1129-1131. Available at: http://www.cdc.gov/ mmwr/preview/mmwrhtml/mm5643a2.htm. Accessed 25 July 2008.
3. Ruel G, Couillard C. Evidences of the cardioprotective potential of fruits: the case of cranberries. Mol Nutr Food Res. 2007;51:692-701.
4. Kuriyama S. The relation between green tea consumption and cardiovascular disease as evidenced by epidemiological studies. J Nutr. 2008;138(Suppl):S1548- S1553.
5. Hooper L, Kroon PA, Rimm EB, et al. Flavonoids, flavonoid-rich foods, and cardiovascular risk: a meta-analysis of randomized controlled trials. Am J Clin Nutr. 2008;88:38-50.
6. Kris-Etherton PM, Lefevre M, Beecher GR, Gross MD, Keen CL, Etherton TD. Bioactive compounds in nutrition and healthresearch methodologies for establishing biological function: the antioxidant and anti-inflammatory effects of flavonoids on atherosclerosis. Annu Rev Nutr. 2004;24:511-538.
7. Law MR, Morris JK. By how much does fruit and vegetable consumption reduce the risk of ischaemic heart disease? Eur J Clin Nutr. 1998;52:549-556.
8. Joshipura KJ, Hu FB, Manson JE, et al. The effect of fruit and vegetable intake on risk for coronary heart disease. Ann Intern Med. 2001;34:1106-1114.
9. Joshipura KJ, Ascherio A, Manson JE, et al. Fruit and vegetable intake in relation to risk of ischemic stroke. JAMA. 1999;282:1233-1239.
10. Iribarren C, Folsom AR, Jacobs DR Jr, Gross MD, Belcher JD, Eckfeldt JH. Association of serum vitamin levels, LDL susceptibility to oxidation, and autoantibodies against MDA-LDL with carotid atherosclerosis. A case-control study. The ARIC Study Investigators. Atherosclerosis risk in communities. Arterioscler Thromb Vasc Biol. 1997;17:1171-1177.
11. Sesso HD, Buring JE, Norkus EP, Gaziano JM. Plasma lycopene, other carotenoids, and retinol and the risk of cardiovascular disease in women. Am J Clin Nutr. 2004;79:47-53.
12. Erlund I, Koli R, Alfthan G, et al. Favorable effects of berry consumption on platelet function, blood pressure, and HDL cholesterol. Am J Clin Nutr. 2008;87:323-331.
13. Fukao H, Ijiri Y, Miura M, et al. Effect of trans-resveratrol on the thrombogenicity and atherogenicity in apolipoprotein E-deficient and low-density lipoprotein receptor-deficient mice. Blood Coagul Fibrinolysis. 2004;15:441-446.
14. Heber D, Seeram NP, Wyatt H, et al. Safety and antioxidant activity of a pomegranate ellagitannin-enriched polyphenol dietary supplement in overweight individuals with increased waist size. J Agric Food Chem. 2007;55:10050-10054.
15. Nettleton JA, Steffen LM, Mayer-Davis EJ, et al. Dietary patterns are associated with biochemical markers of inflammation and endothelial activation in the Multi-Ethnic Study of Atherosclerosis (MESA). Am J Clin Nutr. 2006;83:1369-1379.
16. Ackermann RT, Mulrow CD, Ramirez G, et al. Garlic shows promise for improving some cardiovascular risk factors. Arch Intern Med. 2001;161:813-824.
17. Tipoe GL, Leung TM, Hung MW, Fung ML. Green tea polyphenols as an anti-oxidant and anti-inflammatory agent for cardiovascular protection. Cardiovasc Hematol Disord Drug Targets. 2007;7:135-144.
18. Cho SY, Park SJ, Kwon MJ, et al. Quercetin suppresses proinflammatory cytokine production through MAP kinases and NF-kappaB pathway in lipopolysaccharide-stimulated macrophage. Mol Cell Biochem. 2003;243:153-160.
19. Bhatt DL. Anti-inflammatory agents and antioxidants as a possible "third great wave" in cardiovascular secondary prevention. Am J Cardiol. 2008;101:4D-13D.
20. Basu A, Lucas EA. Mechanisms and effects of green tea on cardiovascular health. Nutr Rev. 2007;65:361-375.
21. U.S. Department of Agriculture (USDA). U.S. Department of Health and Human Services. Dietary Guidelines for Americans 2005. Food Groups to Encourage. Available at: http:// www.health.gov/dietaryguidelines/dga2005/document/ html/chapter5.htm. Accessed 28 July 2008.
22. Seeram NP. Berry fruits: compositional elements, biochemical activities, and the impact of their intake on human health, performance, and disease. J Agric Food Chem. 2008;56:627-629.
23. Aviram M, Rosenblat M, Gaitini D, et al. Pomegranate juice consumption for 3 years by patients with carotid artery stenosis reduces common carotid intima-media thickness, blood pressure and LDL oxidation. Clin Nutr. 2004;23:423-433.
24. Sumner MD, Elliott-Eller M, Weidner G, et al. Effects of pomegranate juice consumption on myocardial perfusion in patients with coronary heart disease. Am J Cardiol. 2005;96:810-814.
25. Chun OK, Chung SJ, Claycombe KJ, Song WO. Serum C-reactive protein concentrations are inversely associated with dietary flavonoid intake in U.S. adults. J Nutr. 2008;138:753-760.
26. Ellingsen I, Hjerkinn EM, Seljeflot I, Arnesen H, Tonstad S. Consumption of fruit and berries is inversely associated with carotid atherosclerosis in elderly men. Br J Nutr. 2008;99:674-681.
27. Fan J, Watanabe T. Inflammatory reactions in the pathogenesis of atherosclerosis. J Atheroscler Thromb. 2003;10:63-71.
28. Holvoet P. Relations between metabolic syndrome, oxidative stress and inflammation and cardiovascular disease [in Dutch]. Verh K Acad Geneeskd Belg. 2008;70:193-219.
29. Kals J, Kampus P, Kals M, et al. Inflammation and oxidative stress are associated differently with endothelial function and arterial stiffness in healthy subjects and in patients with atherosclerosis. [Published online ahead of print April 9 2008] Scand J Clin Lab Invest. 2008;68:1-8. Available at: http://www.ncbi.nlm.nih.gov/sites/entrez. Accessed 29 July 2008.
30. Singh U, Jialal I. Oxidative stress and atherosclerosis. Pathophysiology. 2006;13:129-142.
31. Booth AD, Wallace S, McEniery CM, et al. Inflammation and arterial stiffness in systemic vasculitis: a model of vascular inflammation. Arthritis Rheum. 2004;50:581-588.
32. Couillard C, Ruel G, Archer WR, et al. Circulating levels of oxidative stress markers and endothelial adhesion molecules in men with abdominal obesity. J Clin Endocrinol Metab. 2005;90:6454-6459.
33. Davì G, Guagnano MT, Ciabattoni G, et al. Platelet activation in obese women: role of inflammation and oxidant stress. JAMA. 2002;288:2008-2014.
34. Vasdev S, Gill VD, Singal PK. Modulation of oxidative stressinduced changes in hypertension and atherosclerosis by antioxidants. Exp Clin Cardol. 2006;11:206-216.
35. Flouris AD, Faught BE, Klentrou P. Cardiovascular disease risk in adolescent smokers: evidence of a smoker lifestyle. J Child Health Care. 2008;12:221-231.
36. Neumann AI, Martins IS, Marcopito LF, Araujo EA. Dietary patterns associated with risk factors for cardiovascular disease in a Brazilian city. Rev Panam Salud Publica. 2007;22:329-339.
37. Kamphuis MH, Geerlings MI, Tijhuis MA, et al. Physical inactivity, depression, and risk of cardiovascular mortality. Med Sci Sports Exerc. 2007;39:1693-1699.
38. Gordon JL, Lavoie KL, Arsenault A, Ditto B, Bacon SL. Health behaviors and endothelial function. J Behav Med. 2008;31:5-21.
39. Wiersma JJ, Meuwese MC, van Miert JN, et al. Diabetes mellitus type 2 is associated with higher levels of myeloperoxidase. Med Sci Monit. 2008;14:CR 406-410.
40. Valko M, Leibfritz D, Moncol J, Cronin MT, Mazur M, Telser J. Free radicals and antioxidants in normal physiological functions and human disease. Int J Biochem Cell Biol. 2007;39:44-84.
41. Ceriello A, Motz E. Is oxidative stress the pathogenic mechanism underlying insulin resistance, diabetes, and cardiovascular disease? The common soil hypothesis revisited. Arterioscler Thromb Vasc Biol. 2004;24:816-823.
42. Lavi S, Yang EH, Prasad A, et al. The interaction between coronary endothelial dysfunction, local oxidative stress, and endogenous nitric oxide in humans. Hypertension. 2008; 51:127-133.
43. Kals J, Kampus P, Kals M, et al. Impact of oxidative stress on arterial elasticity in patients with atherosclerosis.AmJ Hypertens. 2006;19:902-908.
44. Hattori Y, MatsumuraM, Kasai K. Vascular smooth muscle cell activation by C-reactive protein. Cardiovasc Res. 2003;58: 186-195.
45. Yung LM, Leung FP, Yao X, Chen ZY, Huang Y. Reactive oxygen species in vascular wall. Cardiovasc Hematol Disord Drug Targets. 2006;6:1-19.
46. Packard RR, Libby P. Inflammation in atherosclerosis: from vascular biology to biomarker discovery and risk prediction. Clin Chem. 2008;54:24-38.
47. Libby P, Ridker PM, Maseri A. Inflammation and atherosclerosis. Circulation. 2002;105:1135-1143.
48. Steinberg D, Witztum JL. Is the oxidative modification hypothesis relevant to human atherosclerosis? Do the antioxidant trials conducted to date refute the hypothesis? Circulation. 2002;105:2107-2111.
49. Grattagliano I, Palmieri VO, Portincasa P, Moschetta A, Palasciano G. Oxidative stress-induced risk factors associated with the metabolic syndrome: a unifying hypothesis. J Nutr Biochem. 2008;19:491-504.
50. Qamirani E, Ren Y, Kuo L, Hein TW. C-reactive protein inhibits endothelium-dependent NO-mediated dilation in coronary arterioles by activating p38 kinase and NAD(P)H oxidase. Arterioscler Thromb Vasc Biol. 2005;25:995-1001.
51. Matsuura E, Kobayashi K, Tabuchi M, Lopez LR. Oxidative modification of low-density lipoprotein and immune regulation of atherosclerosis. Prog Lipid Res. 2006;45:466-486.
52. Alexopoulos N, Vlachopoulos C, Aznaouridis K, et al. The acute effect of green tea consumption on endothelial function in healthy individuals. Eur J Cardiovasc Prev Rehabil. 2008;15:300-305.
53. Shih PH, Yeh CT, Yen GC. Anthocyanins induce the activation of phase II enzymes through the antioxidant response element pathway against oxidative stress-induced apoptosis. J Agric Food Chem. 2007;55:9427-9435.
54. Aviram M, Volkova N, Coleman R, et al. Pomegranate phenolics from the peels, arils, and flowers are antiatherogenic: studies in vivo in atherosclerotic apolipoprotein e-deficient (E 0) mice and in vitro in cultured macrophages and lipoproteins. J Agric Food Chem. 2008;56:1148-1157.
55. de Nigris F, Balestrieri ML, Williams-Ignarro S, et al. The influence of pomegranate fruit extract in comparison to regular pomegranate juice and seed oil on nitric oxide and arterial function in obese Zucker rats. Nitric Oxide. 2007;17:50-54.
56. Terao J, Kawai Y, Murota K. Vegetable flavonoids and cardiovascular disease. Asia Pac J Clin Nutr. 2008;17(Suppl 1):291-293.
57. Spiller F, Alves MK, Vieira SM, et al. Anti-inflammatory effects of red pepper (Capsicum baccatum) on carrageenan- and antigen-induced inflammation. J Pharm Pharmacol. 2008;60: 473-478.
58. Tribolo S, Lodi F, Connor C, et al. Comparative effects of quercetin and its predominant human metabolites on adhesion molecule expression in activated human vascular endothelial cells. Atherosclerosis. 2008;197:50-56.
59. Mertens-Talcott SU, Jilma-Stohlawetz P, Rios J, Hingorani L, Derendorf H. Absorption, metabolism, and antioxidant effects of pomegranate (Punica granatum L.) polyphenols after ingestion of a standardized extract in healthy human volunteers. J Agric Food Chem. 2006;54:8956-8961.
60. Seeram NP, Aviram M, Zhang Y, et al. Comparison of antioxidant potency of commonly consumed polyphenol-rich beverages in the United States. J Agric Food Chem. 2008;56: 1415-1422.
61. Gil MI, Tomás-Barberán FA, Hess-Pierce B, Holcroft DM, Kader AA. Antioxidant activity of pomegranate juice and its relationship with phenolic composition and processing. J Agric Food Chem. 2000;48:4581-4589.
62. Azadzoi KM, Schulman RN, Aviram M, Siroky MB. Oxidative stress in arteriogenic erectile dysfunction: prophylactic role of antioxidants. J Urol. 2005;174:386-393.
63. Rosenblat M, Aviram M. Antioxidative properties of pomegranate: in vitro studies. In: Seeram NP, Heber D, eds. Pomegranates: Ancient Roots to Modern Medicine. New York, NY: Taylor and Francis Group; 2006:31-43.
64. Seeram NP, Lee R, Heber D. Bioavailability of ellagic acid in human plasma after consumption of ellagitannins from pomegranate (Punica granatum L.) juice. Clin Chim Acta. 2004;348:63-68.
65. Seeram NP, Aviram M, Volkova N, Zhang Y, Henning SM, Nair M, Heber D. Dietary polyphenols derived from pomegranates are potent antioxidants: evaluation in various in vitro models of antioxidation. In: 228th National Meeting of the American Chemical Society, American Chemical Society, Philadelphia, PA, 2004. Abstract AGFD44.
66. Seeram NP, Henning SM, Zhang Y, Suchard M, Li Z, Heber D. Pomegranate juice ellagitannin metabolites are present in human plasma and some persist in urine for up to 48 hours. J Nutr. 2006;136:2481-2485.
67. Cerdá B, Espín JC, Parra S,Martínez P, Tomás-Barberán FA. The potent in vitro antioxidant ellagitannins from pomegranate juice are metabolised into bioavailable but poor antioxidant hydroxy-6H-dibenzopyran-6-one derivatives by the colonic microflora of healthy humans. Eur J Nutr. 2004;43:205-220.
68. Cerdá B, Soto C, Albaladejo MD, et al. Pomegranate juice supplementation in chronic obstructive pulmonary disease: a 5-week randomized, double-blind, placebo-controlled trial. Eur J Clin Nutr. 2006;60:245-253.
69. Aviram M, Dornfeld L, Rosenblat M, et al. Pomegranate juice consumption reduces oxidative stress, atherogenic modifications of LDL, and platelet aggregation: studies in humans and in atherosclerotic apolipoprotein E-deficient mice. Am J Clin Nutr. 2000;71:1062-1076.
70. Aviram M, Dornfeld L, Kaplan M, et al. Pomegranate juice flavonoids inhibit LDL oxidation and cardiovascular disease: studies in atherosclerotic mice and in humans. Drugs Exp Clin Res. 2002;28:49-62.
71. Aviram M. Pomegranate juice as a major source for polyphenolic flavonoids and it is most potent antioxidant against LDL oxidation and atherosclerosis. Free Radic Res. 2002;36(Suppl 1):71-73.
72. Kaplan M, Hayek T, Raz A, et al. Pomegranate juice supplementation to atherosclerotic mice reduces macrophage lipid peroxidation, cellular cholesterol accumulation and development of atherosclerosis. J Nutr. 2001;131:2082-2089.
73. Napoli C, Ignarro LJ. Nitric oxide and atherosclerosis. Nitric Oxide. 2001;5:88-97.
74. Ignarro LJ, Byrns RE, Sumi D, de Nigris F, Napoli C. Pomegranate juice protects nitric oxide against oxidative destruction and enhances the biological actions of nitric oxide. Nitric Oxide. 2006;15:93-102.
75. Shukla M, Gupta K, Rasheed Z, Khan KA, Haqqi TM. Consumption of hydrolyzable tannins-rich pomegranate extract suppresses inflammation and joint damage in rheumatoid arthritis. Nutrition. 2008;24:733-743.
76. Sartippour MR, Seeram NP, Rao JY, et al. Ellagitannin-rich pomegranate extract inhibits angiogenesis in prostate cancer in vitro and in vivo. Int J Oncol. 2008;32:475-480.
77. Albrecht M, Jiang W, Kumi-Diaka J, et al. Pomegranate extracts potently suppress proliferation, xenograft growth, and invasion of human prostate cancer cells. J. Med. Food. 2004;7:274-283.
78. Cerdá B, Cerón JJ, Tomás-Barberán FA, Espín JC. Repeated oral administration of high doses of the pomegranate ellagitannin punicalagin to rats for 37 days is not toxic. J Agric Food Chem. 2003;51:3493-3501.
79. Esmaillzadeh A, Tahbaz F, Gaieni I, Alavi-Majd H, Azadbakht L. Concentrated pomegranate juice improves lipid profiles in diabetic patients with hyperlipidemia. J Med Food. 2004;7: 305-308.
80. Rosenblat M, Hayek T, Aviram M. Anti-oxidative effects of pomegranate juice (PJ) consumption by diabetic patients on serum and on macrophages. Atherosclerosis. 2006;187:363-371.
81. Aviram M, Dornfeld L. Pomegranate juice consumption inhibits serum angiotensin converting enzyme activity and reduces systolic blood pressure. Atherosclerosis. 2001;158: 195-198.
82. Tipoe GL, Leung TM, Hung MW, Fung ML. Green tea polyphenols as an anti-oxidant and anti-inflammatory agent for cardiovascular protection. Cardiovasc Hematol Disord Drug Targets. 2007;7:135-144.
83. Misra A, Chattopadhyay R, Banerjee S, Chattopadhyay DJ, Chatterjee IB. Black tea prevents cigarette smoke-induced oxidative damage of proteins in guinea pigs. J Nutr. 2003;133:2622-2628.
84. Hofmann T, Liegibel U,Winterhalter P, Bub A, Rechkemmer G, Pool-Zobel BL. Intervention with polyphenol-rich fruit juices results in an elevation of glutathione S-transferase P1 (hGSTP1) protein expression in human leucocytes of healthy volunteers. Mol Nutr Food Res. 2006;50:1191-1200.